Dr. Gruenbaum, of Blood Cancer United, discusses menin inhibitors in AML
In this SOHO Insider interview from the American Society of Hematology Annual Meeting & Exposition, Lore Gruenbaum, PhD, chief scientific officer at Blood
In this SOHO Insider interview from the American Society of Hematology Annual Meeting & Exposition, Lore Gruenbaum, PhD, chief scientific officer at Blood
The United States Food and Drug Administration selected the supplemental Biologics License Application for teclistamab (TECVAYLI) plus daratumumab and hyaluronidase-fihj (DARZALEX FASPRO) to
LOS ANGELES—SOHO Insider, the official media platform of the Society of Hematologic Oncology (SOHO) has announced the launch of its Virtual Community Oncology
The FDA has granted priority review nivolumab in combination with doxorubicin, vinblastine and dacarbazine (AVD) for adult and pediatric patients who are 12
Dr. Nina Shah, Global Head of Multiple Myeloma Clinical Development and Strategy at AstraZeneca presents "How Can Pharma Engage with Community Oncologists"
Shakira Grant, MBBS, MSCR, Founder and CEO of CROSS Global Research & Strategy, LLC, will present "AI Impacting Pathology and Treatment Decisions" on
Hans Lee, MD, Director of Myeloma Research at Sarah Cannon Research Institute presents "Increasing US Representation in Global Clinical Trials"
Xavier Marin, MD, Hematologist, Scripps Clinic Medical Group, will present "Integrating New Evidence into Everyday Practice" on August 11, 2026 (time TBD).
Dr. Gwen Nichols leads a discussion at 12:15 pm CST on July 13, 2026, on addressing funding gaps in blood cancer research.
SOHO Asia 2026 will focus on the latest advances in leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms (MPNs), featuring leading experts from across